Contribution of IL-17 to mouse hepatitis virus strain 3-induced acute liver failure

Abstract

Recently, the Th17 cells and IL-17 have been shown to play a critical role in the immune-mediated liver injury in hepatitis B, while their functions in acute liver failure have not been well elucidated yet. In this study, we primarily investigated the role of IL-17 in the development of mouse hepatitis virus strain 3 (MHV-3)-induced acute liver failure. IL-17 mRNA levels in liver tissue were quantified by using quantitative real-time polymerase chain reaction, and cytokine IL-17 levels in liver tissue and serum were determined by using ELISA in MHV-3-induced murine fulminant hepatitis model. The IL-17 expression levels on CD4⁺T and CD8⁺T cells were determined by using flow cytometry. The correlation between IL-17 level and liver injury was studied. Th17 associated cytokines were also investigated by intracellular staining. Our results showed that the IL-17 expression was significantly elevated in the liver and serum of BALB/cJ mice infected with MHV-3. Moreover, a time course study showed that the percentage of both IL-17-producing CD4⁺T cells and IL-17-producing CD8⁺T cells was increased remarkably in the liver starting from 48 h and peaked at 72 h post-infection. There was a close correlation between hepatic or serum IL-17 concentration and the severity of liver injury defined by ALT level, respectively. Th17 associated cytokines, IL-6, IL-21 and IL-22, were also increased significantly at 72 h post-infection. It was concluded that IL-17 may contribute to the pathogenesis of MHV-3-induced acute liver failure.

Keywords

Th17 cell / IL-17 / MHV-3 / acute liver failure / virus-induced liver injury

References

[1] KhaderS.A., GopalR.. IL-17 in protective immunity to intracellular pathogens. Virulence, 2010, 1(5): 423-427

[2] KornT., BettelliE., OukkaM., et al.. IL-17 and Th17 cells. Annu Rev Immunol, 2009, 27: 485-517

[3] ZhaoL., TangY., YouZ., et al.. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One, 2011, 6(4): e18909

[4] HammerichL., HeymannF., TackeF.. Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol, 2011, 2011: 345803

[5] YeC., LiW.Y., ZhengM.H., et al.. T-helper 17 cell: A distinctive cell in liver diseases. Hepatol Res, 2011, 41(1): 22-29

[6] RowanA.G., FletcherJ.M., RyanE.J., et al.. Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta. J Immunol, 2008, 181(7): 4485-4494

[7] ZhangF., YaoS., YuanJ., et al.. Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J, 2011, 8: 270

[8] ZhangJ.Y., ZhangZ., LinF., et al.. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology, 2010, 51(1): 81-91

[9] WuW., LiJ., ChenF., et al.. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol, 2010, 25(4): 750-757

[10] GeJ., WangK., MengQ.H., et al.. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol, 2010, 30(1): 60-67

[11] MarsdenP.A., NingQ., FungL.S., et al.. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest, 2003, 112(1): 58-66

[12] NingQ., BrownD., ParodoJ., et al.. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol, 1998, 160(7): 3487-3493

[13] XuS., HanY., XuX., et al.. IL-17A-producing gammadeltaT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation. J Immunol, 2010, 185(10): 5879-5887

[14] LemmersA., MorenoC., GustotT., et al.. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology, 2009, 49(2): 646-657

[15] YasumiY., TakikawaY., EndoR., et al.. Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol Res, 2007, 37(4): 248-254

[16] ZenewiczL.A., YancopoulosG.D., ValenzuelaD.M., et al.. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity, 2007, 27(4): 647-659

[17] YeY., XieX., YuJ., et al.. Involvement of Th17 and Th1 effector responses in patients with hepatitis B. J Clin Immunol, 2010, 30(4): 546-555

[18] NagataT., McKinleyL., PeschonJ.J., et al.. Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. J Immunol, 2008, 181(11): 7473-7479

[19] YanS., WangL., LiuN., et al.. Critical role of interleukin-17/interleukin-17 receptor axis in mediating Con A-induced hepatitis. Immunol Cell Biol, 2012, 90(4): 421-428

[20] YuH., HuangJ., LiuY., et al.. IL-17 contributes to autoimmune hepatitis. J Huazhong Univ Sci Technolog Med Sci, 2010, 30(4): 443-446

[21] LafdilF., WangH., ParkO., et al.. Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production. Gastroenterology, 2009, 137(6): 2125-2135

[22] KobayashiE., KobayashiM., TsuneyamaK., et al.. Halothane-induced liver injury is mediated by interleukin-17 in mice. Toxicol Sci, 2009, 111(2): 302-310

[23] DongC.. Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol Rev, 2008, 226: 80-86

[24] OuyangW., KollsJ.K., ZhengY.. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity, 2008, 28(4): 454-467

[25] LafdilF., MillerA.M., KiS.H., et al.. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol, 2010, 7(4): 250-254

[26] ZhangY., CobleighM.A., LianJ.Q., et al.. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology, 2011, 141(5): 1897-1906